School of Basic Medicine, Zhejiang Chinese Medicine University, Hangzhou, China.
The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
Ann Palliat Med. 2021 Oct;10(10):10506-10514. doi: 10.21037/apm-21-2233.
Research has shown that traditional Chinese medicine (TCM) can achieve good results in the treatment of angina pectoris. In this study, we aimed to explore the therapeutic effect of TCM in the treatment of angina pectoris of coronary heart disease (CHD) through a literature search and meta-analysis.
The PubMed, Embase, CBM (China Biology Medicine) Web of Science databases were searched for studies on the treatment of angina pectoris of CHD with TCM. Inclusion and exclusion criteria were applied, and high-quality articles published from 2010.1 to 2021.8 were selected. The RevMan 5.3.5 software was used to evaluate the therapeutic effect indicators of TCM.
Nine studies involving 824 patients were included in the meta-analysis, and the overall risk of literature bias was low. The results of meta-analysis showed that compared with conventional Western medicine, TCM + conventional Western medicine had a better efficacy indicators of angina pectoris using the fixed-effects model [odd rate (OR) =3.20, 95% confidence interval (CI): (2.09, 4.90), Z=5.35, P<0.00001]. The frequency of angina pectoris was measured by random-effects model, and the statistical results were [standard mean difference (SMD) =-1.85, 95% CI: (-2.29, -1.41), Z=8.22, P<0.00001]. The adverse events was measured by fixed-effects model, and the statistical results were [OR =0.48, 95% CI: (0.21, 1.08), Z=1.78, P=0.08].
The application of TCM in the treatment of angina pectoris of CHD can improve the therapeutic effect, reduce the frequency of angina pectoris, shorten the attack time, reduce serum total cholesterol, and improve the quality of life after treatment, but it has no obvious reducing effect on blood lipids.
研究表明,中医(TCM)在心绞痛的治疗中能取得良好的效果。本研究旨在通过文献检索和荟萃分析探讨 TCM 在冠心病心绞痛治疗中的疗效。
检索 PubMed、Embase、CBM(中国生物医学文献数据库)、Web of Science 数据库中关于 TCM 治疗冠心病心绞痛的研究,纳入和排除标准,选择 2010.1-2021.8 发表的高质量文章。采用 RevMan 5.3.5 软件评估 TCM 的治疗效果指标。
共纳入 9 项研究,共 824 例患者,纳入文献的整体风险偏倚低。Meta 分析结果表明,与常规西药相比,TCM+常规西药在心绞痛疗效指标上有更好的效果[比值比(OR)=3.20,95%置信区间(CI):(2.09,4.90),Z=5.35,P<0.00001]。采用随机效应模型测量心绞痛发作频率,统计结果为[标准均数差(SMD)=-1.85,95%CI:(-2.29,-1.41),Z=8.22,P<0.00001]。采用固定效应模型测量不良反应,统计结果为[OR=0.48,95%CI:(0.21,1.08),Z=1.78,P=0.08]。
TCM 应用于冠心病心绞痛的治疗可以提高疗效,降低心绞痛发作频率,缩短发作时间,降低血清总胆固醇,提高治疗后生活质量,但对血脂无明显降低作用。